Quiz: Epidemiology and Prognosis in Ovarian Cancer

Article

How much do you know about the epidemiology and prognosis of ovarian cancer? Here's your chance to find out.

In our August ovarian cancer quiz, you’ll get a chance to test your knowledge on the epidemiology and prognosis of this disease. Here’s your first question:

1.  Pain is independently associated with overall survival time among women with recurrent ovarian cancer.

A.True

B.False


Recent Videos
Interim data reveal favorable responses in patients with low-grade serous ovarian cancer treated with avutometinib plus defactinib, according to Susana N. Banerjee, MD.
Treatment with mirvetuximab soravtansine appears to produce a 3-fold improvement in objective response rate vs chemotherapy among patients with folate receptor-α–expressing, platinum-resistant ovarian cancer in the phase 3 MIRASOL trial.
PRGN-3005 autologous UltraCAR-T cells appear well-tolerated and decreases tumor burden in a population of patients with advanced platinum-resistant ovarian cancer.
An expert from Dana-Farber Cancer Institute discusses findings from the final overall survival analysis of the phase 3 ENGOT-OV16/NOVA trial.